<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR66006</article-id>
      <title-group>
        <article-title>A Comprehensive Review On Structural and Biological Activity Relationship of 3-Acetoxyazetidin-2-Ones</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bhalla</surname>
            <given-names>Aman</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Narula</surname>
            <given-names>Dipika</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bari</surname>
            <given-names>Shamsher S.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2016-12-01">
        <month>12</month>
        <day>01</day>
        <year>2016</year>
      </pub-date>
      <volume>6</volume>
      <issue>6</issue>
      <abstract>
        <p>Azetidin-2-ones (β-lactams) have been a mainstay as therapeutics for the treatment of a wide range of bacterial infections. The interest in β-lactams stems from their highly unusual structure-activity profiles towards a genera of pathogenic bacteria. Tremendous efforts have been made in the literature towards the development of novel β-lactam compounds for a study of their biological evaluation. The present review begins with a brief introduction of β-lactam antibiotics. This is preceded by the progress made towards the biological evaluation of a variety of racemic as well as optically active cis- or trans-3-acetoxyazetidin-2-ones. Their application in medicinal field as antifungal, antibacterial, antitumor, anticancer, IMR32 cytotoxic agents and carbonic anhydrase inhibitors is discussed.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>3-Acetoxyazetidin-2-ones</kwd>
        <kwd>antifungal</kwd>
        <kwd>antibacterial</kwd>
        <kwd>antitumor</kwd>
        <kwd>anticancer</kwd>
        <kwd>carbonic anhydrase inhibitor</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
